Research Paper Volume 12, Issue 22 pp 23200—23216

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma

Figure 4. Prognostic value of the epigenetic signature using the training set. (A) Rankings for the risk signature and group distribution. (B) Survival status of patients in the low- and high-risk groups. (C) Heatmap of the gene-expression profiles. (D) Patients in the high-risk group demonstrated poor OS. (E) ROC curve showing the prognostic significance of the risk signature. (F) Univariate and (G) multivariate Cox regression analyses of discrete clinical factors.